In early 2024, the Janus Worldwide team launched a large-scale initiative to implement its proprietary AI plugin in real-world production scenarios. The approach was practical and business-oriented: how to reduce translation costs without sacrificing quality, especially in the face of limited budgets and strict client deadlines.
Artificial intelligence has become firmly established in everyday localization processes. However, it is important to understand: not all AI translations are created equal. With increasing demands on quality, deadlines, and stylistic accuracy, machine translation alone is not enough for clients. They need it a real intellectual tool, adapted to their content, style and objectives.
Machine translation, even built on the most modern LLM models, must not only sound smart, but also be objectively qualitative. At Janus Worldwide, we are confident that artificial intelligence is not magic, but a tool whose results can be measure, compare and improve.
In the fast-paced world of medical device manufacturing, safety is always a top priority. However, safety doesn’t just come from high-quality engineering or innovative design. It also hinges on clear communication, especially when it comes to labeling, instructions for use (IFUs), and safety documentation. With the implementation of the EU Medical Device Regulation (MDR 2017/745) and In-vitro Diagnostic Regulation (IVDR 2017/746), these materials are now subject to more stringent localization requirements than ever before.
As 2025 unfolds, the field of multimedia localization is rapidly evolving, shaped by advancements in AI, machine learning, and cloud-based platforms. At Janus Worldwide, we are committed to staying at the forefront of these innovations to deliver cutting-edge localization solutions that ensure global reach and cultural relevance for our clients.
In today’s globalized world, companies are expanding beyond their domestic markets at an unprecedented rate. With this growth comes the need to communicate effectively with diverse audiences, and that’s where localization of marketing materials becomes crucial. At Janus Worldwide, we are committed to helping brands adapt their message to resonate across languages and cultures, ensuring that each communication is not just a translation, but a strategic, culturally-aligned tool for success.
In a world where speed and quality of translation is becoming a strategic advantage for businesses, Janus Worldwide reaffirms its reputation as a technology leader in the industry. We are pleased to introduce LEXA, a new cloud-based platform that combines the best solutions from the company and global machine translation providers into a single intelligent system.
As companies expand across borders, localization has become essential – not just an added value. Success now hinges on delivering culturally relevant experiences, not just translated content.
In clinical research, translation is essential. Every patient deserves to fully understand their consent. Unfortunately, many critical documents like informed consent forms and trial instructions are inadequately translated, leading to confusion, misinformed choices, and potential safety risks.
Janus Worldwidelanguage services and translation technology provider has been named by CSA Research as one of the 2025 Global and Regional Market Leaders. The recognition is based on independently verified 2024 revenue data and highlights companies playing a significant role in the global language services and technology market.